Robert John Mentz, MD

Associate Professor of Medicine
Associate Professor in Population Health Sciences
Member in the Duke Clinical Research Institute
Campus mail Np-8062, Dcri. PO Box 17969, Durham, NC 27715
Phone (919) 668-7121
Email address robert.mentz@duke.edu

I am a cardiologist with a clinical and research interest in heart failure, including advanced therapies such as cardiac transplantation and mechanical assist devices or “heart pumps." I became a heart failure cardiologist in order to help patients manage their chronic disease over many months and years. I consider myself strongly committed to compassionate patient care with a focus on quality of life and patient preference.

My research interests are focused on treating co-morbid diseases in heart failure patients and improving outcomes across the cardiovascular spectrum through clinical trials and outcomes research. Below, you will find my specific research interests:

  •     Co-morbidity characterization (diabetes, sleep apnea, renal failure) in heart failure.
  •     Phenotypic characterization and risk prognostication of patients with heart failure.
  •     Role of surrogate and nonfatal endpoints in clinical heart failure trials.
  •     Biomarkers in heart failure.
  •     Novel pharmacological and non-pharmacological approaches to heart failure.
  •     Improving site-based heart failure research.
In Their Words

Education and Training

  • Fellowship, Advanced Heart Failure, Duke University School of Medicine, 2012 - 2013
  • Fellowship, Clinical Cardiology, Duke University School of Medicine, 2010 - 2012
  • Resident, Internal Medicine, Brigham and Women's Hospital, 2008 - 2010
  • Intern, Internal Medicine, Brigham and Women's Hospital, 2007 - 2008
  • M.D., Emory University, 2003

Publications

McHugh, Kelly R., Adam D. DeVore, Robert J. Mentz, Daniel Edmonston, Jennifer B. Green, and Adrian F. Hernandez. “The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes..” Clin Cardiol 41, no. 9 (September 2018): 1259–67. https://doi.org/10.1002/clc.23054.

PMID
30125365
Full Text

Greene, Stephen J., Robert J. Mentz, Mona Fiuzat, Javed Butler, Scott D. Solomon, Andrew P. Ambrosy, Cyrus Mehta, John R. Teerlink, Faiez Zannad, and Christopher M. O’Connor. “Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure..” Circulation 138, no. 10 (September 2018): 1039–53. https://doi.org/10.1161/circulationaha.118.034668.

PMID
30354535
Full Text

Onwuemene, Oluwatoyosi A., Steven C. Grambow, Chetan B. Patel, Robert J. Mentz, Carmelo A. Milano, Joseph G. Rogers, Ara D. Metjian, Gowthami M. Arepally, and Thomas L. Ortel. “Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study..” J Clin Apher 33, no. 4 (August 2018): 469–79. https://doi.org/10.1002/jca.21622.

PMID
29524240
Full Text

Vaduganathan, Muthiah, Ravi B. Patel, Robert J. Mentz, Haris Subacius, Neal A. Chatterjee, Stephen J. Greene, Andrew P. Ambrosy, et al. “Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)..” Am J Cardiol 122, no. 2 (July 15, 2018): 255–60. https://doi.org/10.1016/j.amjcard.2018.03.362.

PMID
29731121
Full Text

Kelly, Jacob P., Melissa Greiner, Elsayed Z. Soliman, Tiffany C. Randolph, Kevin L. Thomas, Shannon M. Dunlay, Lesley H. Curtis, Emily C. O’Brien, and Robert J. Mentz. “Relation of Early Repolarization (J Point Elevation) to Mortality in Blacks (from the Jackson Heart Study)..” Am J Cardiol 122, no. 2 (July 15, 2018): 340–46. https://doi.org/10.1016/j.amjcard.2018.04.004.

PMID
29866580
Full Text

Mentz, Robert J., and Stephen J. Greene. “Adding Troponin to the Puzzle of Heart Failure With Preserved Ejection Fraction: Marker or Mediator?.” J Am Coll Cardiol 72, no. 1 (July 3, 2018): 41–44. https://doi.org/10.1016/j.jacc.2018.04.038.

PMID
29957230
Full Text

Fudim, Marat, and Robert J. Mentz. “Early versus late readmission during the vulnerable phase following hospitalization for heart failure: reply..” Eur J Heart Fail 20, no. 7 (July 2018). https://doi.org/10.1002/ejhf.1189.

PMID
29600600
Full Text

Verma, Amanda K., Jie-Lena Sun, Adrian Hernandez, John R. Teerlink, Phillip J. Schulte, Justin Ezekowitz, Adriaan Voors, et al. “Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF..” Clin Cardiol 41, no. 7 (July 2018): 945–52. https://doi.org/10.1002/clc.22981.

PMID
29781109
Full Text

Warraich, Haider J., Christopher O’Connor, Angie Wu, Adrian Coles, William E. Kraus, Ileana L. Piña, David J. Whellan, and Robert J. Mentz. “Differences Between Patients Enrolled Early and Late During Clinical Trial Recruitment: Insights From the HF-ACTION Trial..” Circ Cardiovasc Qual Outcomes 11, no. 7 (July 2018). https://doi.org/10.1161/CIRCOUTCOMES.117.004643.

PMID
29980656
Full Text

Greene, Stephen J., Emily C. O’Brien, Robert J. Mentz, Nancy Luo, N Chantelle Hardy, Warren K. Laskey, Paul A. Heidenreich, et al. “Home-Time After Discharge Among Patients Hospitalized With Heart Failure..” J Am Coll Cardiol 71, no. 23 (June 12, 2018): 2643–52. https://doi.org/10.1016/j.jacc.2018.03.517.

PMID
29880124
Full Text

Pages